CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $3.22B, above the global median of $1.15B
- FinancialsAltman Z-Score 4.17: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.29%Below 5Y avg (0.36%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
18.9%Sustainable
Last Ex-Dividend
Jun 9, 2026
The reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
21.66BCNY3.22B · vs all stocks (USD)
Trailing P/E
50.48xRevenue (TTM)
3.73BCNY554.22M · vs all stocks (USD)
Profit Margin
11.82%Beta
0.4540xvs all stocks
52-Week Change
-20.15%vs all stocks
Market Capitalization
21.66BCNY3.22B · vs all stocks (USD)
Enterprise Value
25.56BCNY3.80B · vs all stocks (USD)
Trailing P/E
50.48xForward P/E
31.55xPrice to Sales (TTM)
6.01xPrice to Book (MRQ)
3.28xEnterprise to Revenue
6.85xEnterprise to EBITDA
21.20xGross Margin
79.08%Profit Margin
11.82%Operating Margin
28.50%Return on Assets (TTM)
3.87%Return on Equity (TTM)
6.75%Revenue (TTM)
3.73BCNY554.22M · vs all stocks (USD)
Revenue per Share (TTM)
8.90CNYUpdated Aug 19, 2026Quarterly Revenue Growth
13.30%Gross Profit (TTM)
2.95BCNY437.73M · vs all stocks (USD)
EBITDA (TTM)
627.47MCNY93.19M · vs all stocks (USD)
Net Income (TTM)
441.16MCNY65.52M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
135.70%Operating Cash Flow (TTM)
877.33MCNY130.30M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-310.85MCNY-46.17M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1500CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.29%vs all stocks
5-Year Average Dividend Yield
0.36%vs all stocks
Payout Ratio
18.95%Minority Interest (Equity)
72.53MCNYFY2025 · Dec 31, 2025Revenue
3.61BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
738.66MCNYFY2025 · Dec 31, 2025Gross Profit
2.87BCNYFY2025 · Dec 31, 2025Operating Income
582.79MCNY86.56M · vs all stocks (USD)
Pre-tax Income
414.36MCNYFY2025 · Dec 31, 2025Income Tax Expense
128.15MCNYFY2025 · Dec 31, 2025Net Income
286.21MCNYFY2025 · Dec 31, 2025EBIT
490.50MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.10BCNYFY2025 · Dec 31, 2025Research & Development
510.87MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.04BCNYFY2025 · Dec 31, 2025Other Operating Expenses
44.07MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.29MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
76.14MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
418.26MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
418.26MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
286.21MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
19.12MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-24.31MCNYFY2025 · Dec 31, 2025Free Cash Flow
-640.91MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
429.98MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
286.21MCNYFY2025 · Dec 31, 2025Other Non-cash Items
88.25MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-290.90MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-107.87MCNYFY2025 · Dec 31, 2025Capital Expenditures
-616.60MCNYFY2025 · Dec 31, 2025Purchase of Investments
-312.26MCNYFY2025 · Dec 31, 2025Sale of Investments
999.00KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-927.87MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
880.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-818.34MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-150.76MCNYFY2025 · Dec 31, 2025Other Financing Charges
62.92MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-26.18MCNYFY2025 · Dec 31, 2025Shares Outstanding
420.73MSharesUpdated Aug 19, 2026Float Shares
238.27MSharesUpdated Aug 19, 2026% Held by Insiders
44.47%vs all stocks
% Held by Institutions
9.67%vs all stocks
Total Cash (MRQ)
510.23MCNY75.78M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.21CNYUpdated Aug 19, 2026Total Debt (MRQ)
2.56BCNY380.37M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3732xCurrent Ratio (MRQ)
0.9910xBook Value per Share (MRQ)
16.15CNYUpdated Aug 19, 2026Total Assets
10.57BCNY1.57B · vs all stocks (USD)
Total Current Assets
1.58BCNYFY2025 · Dec 31, 2025Total Liabilities
3.90BCNYFY2025 · Dec 31, 2025Total Non-current Assets
8.99BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.98BCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.92BCNYFY2025 · Dec 31, 2025Cash
426.24MCNYFY2025 · Dec 31, 2025Cash Equivalents
3.74MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
429.98MCNYFY2025 · Dec 31, 2025Other Short-term Investments
66.00MCNYFY2025 · Dec 31, 2025Accounts Receivable
351.26MCNYFY2025 · Dec 31, 2025Inventory
381.16MCNYFY2025 · Dec 31, 2025Accounts Payable
512.32MCNYFY2025 · Dec 31, 2025Short-term Debt
875.84MCNYFY2025 · Dec 31, 2025Other Current Liabilities
11.33MCNYFY2025 · Dec 31, 2025Long-term Debt
1.53BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
37.74MCNYFY2025 · Dec 31, 2025Common Stock (Book)
420.73MCNYFY2025 · Dec 31, 2025Retained Earnings
2.85BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.67BCNY990.28M · vs all stocks (USD)
52-Week Low
40.10CNYUpdated Aug 19, 202652-Week High
79.80CNYUpdated Aug 19, 202652-Week Change
-20.15%vs all stocks
Beta
0.4540xvs all stocks
50-Day MA
61.27CNYUpdated Aug 19, 2026200-Day MA
51.01CNYUpdated Aug 19, 2026Avg 10-Day Volume
19.74MSharesUpdated Aug 19, 2026Avg 30-Day Volume
19.08MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
1.05CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.13Receivables vs revenue divergence: 3.95
Financial Health
Altman Z-Score 4.17: safe zoneNotable
Altman Z-Score: 4.17
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $3.22B, above the global median of $1.15BNotable
Market cap (USD): 3,217,222,762.315Global Median: 1,146,734,693.424
Revenue is $554.22M, above the global median of $520.53MNotable
Revenue (USD): 554,220,102.595Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
ABL Bio Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Integer Holdings Corporation
Tier 1ProductionApproval-Gated PipelineRule
Wockhardt Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jilin Aodong Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hybio Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
BioArctic AB
Tier 1ProductionApproval-Gated PipelineRuleRisk
Lepu Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Haoyuan Chemexpress Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Kanghong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Harbin Pharmaceutical Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow